SEC Form 4 · accession 0001225208-18-013192
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Bobo Jr.
Officer — CVP,Strategy/Corp Development
Period of report
Aug 31, 2018
Accepted (ET)
Sep 5, 2018 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2018 | S | 75 | $144.2449 | D | 19,990 | D | |
| Common Stock | holding | — | — | — | 12,550 | I | 401(k) | |
| Common Stock | holding | — | — | — | 50,785 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.